Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,646,544
  • Shares Outstanding, K 70,347
  • Annual Sales, $ 2,072 M
  • Annual Income, $ 418,300 K
  • EBIT $ 437 M
  • EBITDA $ 518 M
  • 60-Month Beta 1.41
  • Price/Sales 7.24
  • Price/Cash Flow 55.35
  • Price/Book 12.48

Options Overview Details

View History
  • Implied Volatility 48.05% (-2.40%)
  • Historical Volatility 27.40%
  • IV Percentile 80%
  • IV Rank 67.74%
  • IV High 60.02% on 04/10/25
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 8) 21.23 (8.46%)
  • Put/Call Vol Ratio 0.20
  • Today's Volume 120
  • Volume Avg (30-Day) 318
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 7,914
  • Open Int (30-Day) 7,462
  • Expected Range 229.62 to 272.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.48
  • Number of Estimates 10
  • High Estimate 1.86
  • Low Estimate 1.32
  • Prior Year 1.15
  • Growth Rate Est. (year over year) +28.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
240.03 +4.51%
on 02/06/26
289.26 -13.28%
on 01/16/26
-38.19 (-13.21%)
since 01/09/26
3-Month
240.03 +4.51%
on 02/06/26
354.88 -29.31%
on 11/20/25
-75.43 (-23.12%)
since 11/11/25
52-Week
230.05 +9.04%
on 03/10/25
354.88 -29.31%
on 11/20/25
-33.41 (-11.75%)
since 02/11/25

Most Recent Stories

More News
3 Profitable Stocks for Long-Term Investors

3 Profitable Stocks for Long-Term Investors

IBTA : 20.96 (-1.13%)
CSW : 322.01 (+2.27%)
PODD : 250.85 (-0.62%)
2 Cash-Producing Stocks with Impressive Fundamentals and 1 Facing Challenges

2 Cash-Producing Stocks with Impressive Fundamentals and 1 Facing Challenges

DV : 9.61 (-1.44%)
PAY : 24.53 (-2.93%)
PODD : 250.85 (-0.62%)
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates, compatible with Abbott and Dexcom continuous glucose sensors ...

PODD : 250.85 (-0.62%)
2 S&P 500 Stocks to Research Further and 1 Facing Challenges

2 S&P 500 Stocks to Research Further and 1 Facing Challenges

AMAT : 339.88 (+3.29%)
PODD : 250.85 (-0.62%)
ISRG : 496.12 (+0.20%)
What You Need To Know Ahead of Insulet’s Earnings Release

Here’s what analysts are expecting from the underperforming stock Insulet prior to its Q4 earnings.

XLV : 156.25 (+0.59%)
$SPX : 6,941.47 (unch)
PODD : 250.85 (-0.62%)
1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Find Risky

1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Find Risky

BOKF : 135.56 (-0.05%)
PODD : 250.85 (-0.62%)
WMT : 128.77 (+1.63%)
Stocks Recover as Data Storage Companies and Chip Makers Rally

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.08%. March E-mini S&P...

AMAT : 339.88 (+3.29%)
B : 47.64 (+1.47%)
AVGO : 342.76 (+0.68%)
C : 117.39 (-3.90%)
HL : 23.69 (+3.09%)
HSIC : 81.69 (+0.83%)
CDE : 23.08 (+1.05%)
JPM : 310.82 (-2.34%)
AKAM : 94.80 (+0.42%)
ANIP : 76.25 (-4.58%)
$IUXX : 25,201.26 (+0.29%)
UNH : 278.91 (+2.08%)
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced...

PODD : 250.85 (-0.62%)
3 Healthcare Stocks with Exciting Potential

3 Healthcare Stocks with Exciting Potential

COR : 365.70 (+1.58%)
PODD : 250.85 (-0.62%)
ABBV : 220.89 (-0.70%)
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

The Company will host a Digital Health Track panel discussion exploring how human-first design and intelligent automation are transforming chronic care into everyday freedom ...

PODD : 250.85 (-0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 260.02
2nd Resistance Point 256.80
1st Resistance Point 253.82
Last Price 250.85
1st Support Level 247.62
2nd Support Level 244.40
3rd Support Level 241.42

See More

52-Week High 354.88
Fibonacci 61.8% 307.19
Fibonacci 50% 292.46
Fibonacci 38.2% 277.74
Last Price 250.85
52-Week Low 230.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar